Understanding how DNA damage affects brain cells in Huntington's disease

Regulation of HTT-mediated DNA damage repair and chromatin remodeling Complexes

NIH-funded research University of Texas Med Br Galveston · NIH-10932368

This study is looking at how the huntingtin protein, which is linked to Huntington's disease, affects the way brain cells fix their DNA when it's damaged, with the hope of finding new ways to help keep these cells healthy and functioning better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Med Br Galveston NIH-funded
Lab location1 site (Galveston, United States)
Project IDNIH-10932368 on NIH RePORTER

What this research studies

This research investigates the role of DNA damage repair mechanisms in neurons, particularly focusing on Huntington's disease. It examines how the huntingtin protein and its mutations influence the repair of DNA double-strand breaks, which are critical for neuron health. By studying the interactions between DNA repair enzymes and the huntingtin protein, the research aims to uncover potential therapeutic targets that could improve neuronal function and survival in neurodegenerative conditions. The approach includes using advanced genetic and biochemical techniques to analyze the effects of these interactions in both laboratory models and patient-derived cells.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with Huntington's disease or those at risk due to genetic factors.

Not a fit: Patients with neurodegenerative diseases unrelated to DNA damage or those without genetic predisposition to Huntington's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance DNA repair processes in brain cells, potentially slowing the progression of Huntington's disease and other neurodegenerative disorders.

How similar studies have performed: Previous research has shown promising results in understanding DNA repair mechanisms in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

Galveston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.